Clinical Trials Browser

INDUSTRY × Nasopharyngeal Carcinoma × Valganciclovir × Clear all

NCT05166577 2025-03-12

Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC

Phase 1 Terminated

26 enrolled 23 charts

Nasopharyngeal Carcinoma